BIS Certification
CDSCO
CPCB
LMPC
WPC Approval
Global Approvals
TEC
ARAI
BEE
ISO Certification
DGCA Certification
NOC For Steel
APEDA Registration
Business Registration
FSSAI Mark Certification
Legal Services
Trademark Registration
Copyright Registration
Patent Registration
- Regulatory Authority: The Indian drug approval process is regulated by the Central Drugs Standard Control Organization (CDSCO) through the Drugs & Cosmetics Act, 1940.
- Approval Procedure: The procedure CDSCO Drug Approval involves clinical trials approval, submission of Form CT-21/CT-22 (for new drugs), analysis of safety and efficacy data, and ultimate approval by the CDSCO.
- Required Documents: These include data CDSCO Drug Approval from clinical trials, manufacturing information, formulation of drugs, stability studies data, packaging and labeling details, and approvals from other countries (if any).
- Fees Structure (2026):The fees CDSCO Drug Approval will be determined based on the type of drug (new drug, biological drug, vaccine, etc.) and application type; payment will be done via the CDSCO SUGAM portal.
- Timelines and Validity:The timelines for drug approval generally take between 6–12 months. The drug approval license will remain valid until it is revoked or suspended.
Introduction| CDSCO Drug Approval
Drug approval is one of the most essential procedures that play an important role in the safety, effectiveness, and quality of medicinal substances. Drug approval is regulated by the Central Drugs Standard Control Organization (CDSCO). The organization acts according to the Drugs & Cosmetics Act, 1940 and Drugs & Cosmetics Rules, 1945.Taking into consideration the changes that are expected in the pharmaceutical industry in 2026, the Central Drugs Standard Control Organization has improved its drug approval policies, bringing them up to international standards. Companies that want to manufacture, distribute, and sell medicinal substances in India should get approval from CDSCO, especially if the drugs have never been used before.
What is CDSCO Drug Approval?
CDSCO Drug Approval refers to the formal license issued by the CDSCO that permits the manufacture, importation, and marketing of pharmaceutical drugs in India. It is a mandatory process that ensures that the drug approved for use in India is safe, of high quality, and efficacious. The need for such drug approval is most pronounced in cases where a drug is a new drug, vaccine, biological product, or innovation.
Key Points:
- Authorization Process for Regulations: CDSCO Drug Approval Authorization refers to the formal authorization issued by the Central Drugs Standard Control Organization for marketing, manufacturing, and importing of drugs in India.
- Essential for Marketing:Any new CDSCO Drug Approval cannot be put into market use in India without approval by the CDSCO.
- Checks Safety and Efficacy:The authorization procedure guarantees the drug’s safety, efficacy, and quality.
- Applicable to Different Drugs:The authorization process is applicable to new drugs, vaccines, biologicals, and some medical inventions.
- Scientific Assessment Required:Drug authorization is based on scientific assessment of the drug’s clinical trial results, structure, manufacturing process, and testing procedures.
Who Needs CDSCO Drug Approval?
Drug Approval by CDSCO is mandatory for individuals, firms, or organizations engaged in the manufacture, import, sale, or research involving drugs within India. This approval is crucial to ensure that all drugs available in the market are safe, effective, and meet the regulatory requirements laid down by the Central Drugs Standard Control Organization (CDSCO).
Key points:
- Drug Manufacturing Companies: Companies that manufacture CDSCO Drug Approval in India should seek CDSCO approval before commencing production and marketing.
- Drugs Importers:Firms that import drugs into India should have received pre-approval from the regulatory authority to comply with the Indian standards.
- Research Organizations/Sponsors:Clinical Research Organizations and sponsors should seek CDSCO authorization before proceeding with clinical trials.
- Biotechnological/Factories:Biosimilars, vaccines, and other biological products companies need specific approvals from the CDSCO.
- Drug Distributors/Marketers:Firms involved in distributing/marketing CDSCO Drug Approval newly developed drugs should ensure that CDSCO approval is in place.
Types of Drug Approvals in India
- Approval for a New Drug
This type of approval is mandatory for those drug products which have not been previously approved in India.
- Approval for an Import Drug
It is mandatory for companies which plan to bring drugs from abroad into India.
- Manufacturing Authorization
It is needed for the production of drug products within India by domestic manufacturers.
- Clinical Trial Approval
This approval is mandatory prior to any clinical trials to be conducted on human beings in India.
- Biological and Vaccine Approval
It is another form of specialized approval which is necessary for biological and vaccine products.
Regulatory Authority & Committees
Regulation of medicines and its approval process in India is carried out by the Central Government, in conjunction with several expert bodies, which ensure proper evaluation of the safety, efficacy, and quality of medicines.
Keypoints :
1.Central Regulatory Authority :The Central Drugs Standard Control Organization (CDSCO) is the regulatory agency that has control over drug approval, clinical trial approvals, and imports of medicines.
2. Drug Controller General of India (DCGI):The Drug Controller General of India (DCGI) is an officer appointed within CDSCO who makes important decisions regarding approvals of new drugs, clinical trials, and other permissions concerning medicines in India.
3. Subject Expert Committees (SECs):Subject Expert Committees (SECs) are special committees composed of experts of medical and scientific field, who evaluate clinical evidence, safety, and efficacy of medicines prior to making any approval recommendations.
4. Technical Review Committee (TRC):Technical Review Committee (TRC) evaluates all recommendations that have been provided by Subject Expert Committees (SECs).
5. Apex Committee:Apex Committee is the highest body involved in the decision-making process, especially concerning the complex or difficult cases associated with new drugs and clinical trials.
Importance & Benefits of CDSCO Drug Approval
| Importance | Benefits |
| Protects Public Safety: The CDSCO’s clearance is a guarantee that the drug is safe to be used by humans. | Legal Market Clearance:Legalizes the manufacturing, importing, and selling of medicines within India |
| Drug Quality Assurance:It makes sure that the pharmaceutical product has met the necessary standards of quality and production. | Market Entry:Efficient clearance processes aid in faster market entry for the pharmaceutical company. |
| Keeps out Inferior Drugs:The stringent process keeps out fake, sub-standard, and poor-quality drugs. | International Acceptance:Drugs that have been approved by CDSCO are internationally recognized, facilitating exports. |
| Compliance With Regulatory Requirements:The approved drug guarantees that the company is compliant with regulations laid down in the Drugs & Cosmetics Act. | Reputation:Drug approvals build a good reputation for the organization. |
| Improves Trust in Health Care System:The approved drug builds trust in the healthcare system. | Competitive Edge:The drug company gets an edge over its competitors by having approval for its product. |
Step-by-Step CDSCO Drug Approval Process (2026)
1. Pre-Submission Preparation
- Identify the drug category (new drug, biological, etc.)
- Prepare required data including pre-clinical and clinical information
- Ensure compliance with regulatory guidelines
2. Application Submission (SUGAM Portal)
- Register on the CDSCO online portal (SUGAM)
- Submit application forms (such as CT-04, CT-21, CT-22 as applicable)
- Upload all necessary documents and pay prescribed fees
3. Clinical Trial Approval (if required)
- Obtain permission before conducting clinical trials in India
- Submit clinical trial protocol and related data
- Approval is granted after ethical and scientific evaluation
4. Review by Subject Expert Committee (SEC)
- Application is reviewed by expert panels
- Evaluation focuses on safety, efficacy, and risk-benefit analysis
- Recommendations are forwarded for further approval
5. Technical & Apex Committee Review
- Technical Review Committee (TRC) verifies the evaluation
- Apex Committee gives final recommendations in critical cases
6. Grant of Approval by DCGI
- Final approval is issued by the Drug Controller General of India (DCGI)
- Permission is granted for manufacturing, import, or marketing
7. Post-Approval Compliance
- Follow pharmacovigilance and reporting requirements
- Maintain quality standards and labeling compliance
- Renewal or additional permissions may be required for changes
Documents Required for CDSCO Drug Approval
| Document Name | Description |
| Application Forms | Duly filled forms such as CT-04, CT-21, CT-22 based on the type of drug |
| Cover Letter | Introduction of the application stating purpose and drug details |
| Authorization Letter | Authorization from the manufacturer (if submitted by an agent/importer) |
| Drug Composition Details | Complete details of active ingredients and formulation |
| Manufacturing Details | Information about manufacturing process, plant, and GMP compliance |
| Clinical Trial Data | Reports proving safety and efficacy of the drug |
| Pre-Clinical Data | Toxicology and pharmacology study reports |
| Stability Data | Data showing shelf life and storage conditions |
| Labeling & Packaging | Proposed labels, packaging, and product inserts |
| Regulatory Approvals | Approval status from other countries (if applicable) |
| Power of Attorney | Required for authorized agents or importers |
Timelines, Costs, Validity & Renewal
- Timelines: 6–12 months depending on drug type and review process by the Central Drugs Standard Control Organization.
- Costs: Vary based on application type; paid via the SUGAM portal.
- Validity: Generally valid indefinitely unless suspended or cancelled.
- Renewal: Usually not required, but updates/changes may need fresh approval.
Why Choose Diligence Certifications
Diligence Certifications is a dependable consultancy firm that makes it easy to get your drugs approved through CDSCO with their professional guidance, complete document management, and swift execution. They have extensive experience with regulatory needs and can assist firms in getting their products approved under CDSCO regulations swiftly.
Conclusion
Approval by the Central Drugs Standard Control Organization (CDSCO) is a critical phase for guaranteeing the safety, efficacy, and compliance of pharmaceutical drugs in accordance with Indian law. Despite its lengthy procedure involving several documents and evaluations, it serves an important purpose in safeguarding public health.
Frequently Asked Questions (FAQs)
What is CDSCO drug approval?
The Central Drugs Standard Control Organization’s approval for selling or manufacturing drugs in India.
Who requires CDSCO approval?
Drugs manufacturers and importers or companies working with new drugs and clinical studies.
Is CDSCO drug approval compulsory?
Yes, it is mandatory for any drug in India to be marketed.
How long does CDSCO drug approval take?
It generally takes six to twelve months.
What documents are needed?
Clinical study, manufacturing process, formulation, and applications.
What is SUGAM portal?
Online portal to file CDSCO application.
What is meant by new drug in CDSCO?
Drugs that have not been approved in India or having new claims or forms.
Is the approval of clinical trial mandatory?
Yes, for new drugs prior to testing on humans.
What will be the validity of such approval?
Normally valid until withdrawn or cancelled.
Will the approval of clinical trial be denied?
Yes, if safety, efficacy, or documentation requirements are not met.
